Nine reports of tumors in children treated with Novartis' spinal muscular atrophy (SMA) gene therapy Zolgensma raise new ...
Dutch biotech Anaheim Bio, a spin-out of BioMarin-acquired Alesta Therapeutics, has launched with an oversubscribed €40 ...
University of Oxford spinout Alethio Therapeutics has raised $90 million (about €80 million) to take its G6B-targeting ...
The Mainz-based vaccine developer is making progress in its transformation into an oncology company. But its quarterly report ...
Boehringer is turning to China for cancer research in a multibillion-dollar deal with Sino Biopharmaceutical. Six preclinical ...
Bayer brings sevabertinib into the first-line setting in China — but Boehringer is already there: With the approval of ...
French pharmaceutical group Servier has suffered a major setback just four months after completing its $1.55 billion upfront ...
As advanced therapies and vaccines reshape healthcare, Wacker Biotech is emerging as a CDMO partner of choice. With decades ...
Denmark's Genmab said adding its bispecific antibody petosemtamab to MSD's Keytruda (pembrolizumab) cut the risk of death by ...
Swiss pharma group Ferring Pharmaceuticals has agreed to acquire New York-based Gameto for up to $1.3825 billion (€1.24 ...
Swiss big pharma Roche has agreed to license ZW209, an experimental cancer immunotherapy from Vancouver-based Zymeworks, for ...
The Basel region is one of the world’s leading life-science clusters. Pharmaceutical companies, biotech firms and research ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results